Adjuvant chemo tied to better survival in low-risk node-positive breast cancerDecember 16, 2022OncologyBreast Cancer
Cancer researcher banned from federal funding for faking data in nearly 400 images in 16 grant applicationsDecember 15, 2022Business of MedicineMixed TopicsOncologyBreast CancerObesity
Capivasertib/fulvestrant improves progression free survival in breast cancerDecember 14, 2022OncologyBreast Cancer
Gene signature may spare some breast cancer patients from radiationDecember 14, 2022OncologyBreast Cancer
Oral SERD camizestrant prolongs PFS vs. fulvestrant in breast cancerDecember 9, 2022OncologyBreast Cancer
Chemotherapy meets its match against aggressive ER+/HER2– breast cancersDecember 9, 2022OncologyBreast Cancer
Potential cause of worse outcomes among Black breast cancer patients foundDecember 9, 2022Breast CancerOncology
Less than a third of Americans aware of cancer risk from alcoholDecember 6, 2022Preventive CareBreast CancerOncology
Managing trastuzumab deruxtecan adverse events in the real worldDecember 1, 2022OncologyBreast Cancer
Whole breast radiation for breast cancer shown to be safe and effectiveDecember 1, 2022OncologyBreast Cancer
Personalized breast screening a step closer to realityNovember 18, 2022Breast CancerPreventive CareOncology
Novel vaccine approach halts disease after 23 years of breast cancerNovember 18, 2022Breast CancerOncology
Third COVID booster benefits cancer patientsNovember 12, 2022COVID-19 UpdatesBreast CancerMixed TopicsPreventive Care
